Cycloalkanediamine derivatives as novel blood coagulation factor Xa inhibitors

T Nagata, T Yoshino, N Haginoya, K Yoshikawa… - Bioorganic & medicinal …, 2007 - Elsevier
This paper describes the synthesis of orally available potent fXa inhibitors 2 and 3 by
modification of the piperazine part of lead compound 1. Carbonyl derivative 3 showed potent …

Synthesis of 3, 4-diaminobenzoyl derivatives as factor Xa inhibitors

J Yang, G Su, Y Ren, Y Chen - European Journal of Medicinal Chemistry, 2015 - Elsevier
Abstract The coagulation factor Xa (FXa) plays a central role in the blood coagulation
cascade. Recent studies have shown that FXa is a particularly attractive target for the …

Design, synthesis, and biological activity of piperidine diamine derivatives as factor Xa inhibitor

A Mochizuki, Y Nakamoto, H Naito, K Uoto… - Bioorganic & medicinal …, 2008 - Elsevier
Previously, we identified cyclohexane diamine derivative 1 as orally bioavailable factor Xa
inhibitor. We have investigated two racemic cis-piperidine diamine derivatives 2 and 3 …

Design, synthesis and SAR of novel ethylenediamine and phenylenediamine derivatives as factor Xa inhibitors

K Yoshikawa, T Yoshino, Y Yokomizo, K Uoto… - Bioorganic & medicinal …, 2011 - Elsevier
We previously reported on a series of cyclohexanediamine derivatives as highly potent
factor Xa inhibitors. Herein, we describe the modification of the spacer moiety to discover an …

Indoline derivatives II: synthesis and factor Xa (FXa) inhibitory activities

T Noguchi, N Tanaka, T Nishimata, R Goto… - Chemical and …, 2007 - jstage.jst.go.jp
Factor Xa (FXa) is well known to play a pivotal role in blood coagulation, so FXa inhibitor is a
promising drug candidate for prophylaxis and treatment of thromboembolic diseases. In the …

The discovery of YM-60828: a potent, selective and orally-bioavailable factor Xa inhibitor

F Hirayama, H Koshio, N Katayama, H Kurihara… - Bioorganic & medicinal …, 2002 - Elsevier
Since Factor Xa (FXa) is well known to play a central role in thrombosis and hemostasis,
inhibition of FXa is an attractive target for antithrombotic strategies. As a part of our …

Discovery of R-142086 as a factor Xa (fXa) inhibitor: Syntheses and structure–activity relationships of cinnamyl derivatives

T Noguchi, N Tanaka, T Nishimata, R Goto… - Chemical and …, 2009 - jstage.jst.go.jp
To develop a novel and effective anticoagulant with potent and selective factor Xa (FXa)
inhibitory activity, a new series of cinnamyl derivatives with enhanced lipophilicity and …

Design, synthesis and biological activities of orally active coagulation factor Xa inhibitors

T Nagahara, S Katakura, Y Yokoyama… - European journal of …, 1995 - Elsevier
DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITIES OF ORALLY ACTIVE COAGULATION
FACTOR Xa INHIBITORS Page 1 DESIGN, SYNTHESIS AND BIOLOGICAL ACTIVITIES OF …

Structure–activity relationships of potent and selective factor Xa inhibitors: benzimidazole derivatives with the side chain oriented to the prime site of factor Xa

H Ueno, S Katoh, K Yokota, J Hoshi, M Hayashi… - Bioorganic & medicinal …, 2004 - Elsevier
A series of benzimidazole derivatives with the side chain on the nitrogen atom oriented to
the prime site of factor Xa (FXa) were designed and synthesized. Compounds with …

Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors

T Su, Y Wu, B Doughan, K Kane-Maguire… - Bioorganic & medicinal …, 2001 - Elsevier
A series of glycolic and mandelic acid derivatives was synthesized and investigated for their
factor Xa inhibitory activity. These analogues are highly potent and selective inhibitors …